Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients-Reference-Cited by-同舟云学术

Safety and efficacy of a Siddha Medicine fixed regimen for the treatment of asymptomatic and mild COVID-19 patients

Published:2022-07 Issue:3 Volume:13 Page:100589
ISSN:0975-9476
Container-title:Journal of Ayurveda and Integrative Medicine
language:en
Short-container-title:Journal of Ayurveda and Integrative Medicine

Author:

Kannan M.,Sathiyarajeswaran P.,Sasikumar D.,Geetha A.,Mohanapriya M.,Vinod N.P.,Manickam P.,Kanakavalli K.,Parthibhan P.,Pitchiah Kumar M.,Kannan R.,Sivaraman G.

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery

Reference47 articles.

1. Principles of diagnosis in Siddha;Shanmugavelu,2009

2. WHO coronavirus disease (COVID-19) dashboard data [Internet],2021

3. Drug repurposing approach to fight COVID-19;Singh;Pharmacol Rep,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19, its prevention and treatment in the light of Ayush medicines;Pharmacological Research - Natural Products;2024-06

2. In silico network pharmacology study on Glycyrrhiza glabra: Analyzing the immune-boosting phytochemical properties of Siddha medicinal plant against COVID-19;Functional Proteomics;2024

3. In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike protein;Journal of Traditional and Complementary Medicine;2024-01

4. Yoga and Other Alternative Therapies to Fight Against COVID-19 Effectively: A Systematic Review of Randomized Controlled Trials;Indian journal of physical therapy and research;2024-01

5. Reduced SARS-CoV-2 infection risk is associated with the use of Seven-Flavor Herb Tea: A multi-center observational study in Shanghai, China;Journal of Integrative Medicine;2023-07